Ignite Creation Date:
2025-12-24 @ 2:27 PM
Ignite Modification Date:
2026-04-23 @ 3:58 AM
Study NCT ID:
NCT02608359
Status:
WITHDRAWN
Last Update Posted:
2025-02-03
First Post:
2015-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Sponsor:
Johnson & Johnson Private Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2015-11-17
First Submit QC Date:
None
Study First Post Date:
2015-11-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-31
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL